ArticleCell2017
A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.
Article in Cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- MX1Journal of translational medicine · 2026Article
- Regulation of T cell exhaustion and stemness: molecular mechanisms and implications for cancer immunotherapy.Cellular & molecular immunology · 2026Review
- A STUB1-CHIC2 complex inhibits CD8Nature immunology · 2025Article
- Aging Compromises Terminal Differentiation Program of Cytotoxic Effector Lineage and Promotes Exhaustion in CD8Aging cell · 2025Article
- PD-1 involvement in CD8+ tumor-infiltrating lymphocytes in patients with colonic-derived peritoneal adenocarcinoma.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025Article
- Circulating tumor-reactive KIRNature immunology · 2025Article
- Regulation of anti-tumor immunity by metal ion in the tumor microenvironment.Frontiers in immunology · 2024Review
- Transcriptional and epigenetic regulators of human CD8Nature genetics · 2023Article
- Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.Journal of cancer research and clinical oncology · 2023Article
- Massively parallel knock-in engineering of human T cells.Nature biotechnology · 2023Article
- Integrative dissection of gene regulatory elements at base resolution.Cell genomics · 2023Article
- Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function.bioRxiv : the preprint server for biology · 2023Article
- Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma.Journal of translational medicine · 2022Article
- Single-Cell Sequencing of Immune Cells in Human Aortic Dissection Tissue Provides Insights Into Immune Cell Heterogeneity.Frontiers in cardiovascular medicine · 2022Article
- PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.Cancer biomarkers : section A of Disease markers · 2022Article
- Ionic Regulation of T-Cell Function and Anti-Tumour Immunity.International journal of molecular sciences · 2021Review
- Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021Article
- Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.Cell reports · 2021Article
- Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults.Nature aging · 2021Article
- Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1Immunity · 2021Article
Corrections and comments
- Erratum for
Authors and funding
19 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.